These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26943700)

  • 1. Does obesity promote the development of colorectal cancer?
    Blomain ES; Waldman SA
    Expert Rev Anticancer Ther; 2016 May; 16(5):465-7. PubMed ID: 26943700
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis.
    Lin JE; Colon-Gonzalez F; Blomain E; Kim GW; Aing A; Stoecker B; Rock J; Snook AE; Zhan T; Hyslop TM; Tomczak M; Blumberg RS; Waldman SA
    Cancer Res; 2016 Jan; 76(2):339-46. PubMed ID: 26773096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on guanylyl cyclase C in the diagnosis, chemoprevention, and treatment of colorectal cancer.
    Rappaport JA; Waldman SA
    Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1125-1137. PubMed ID: 32945718
    [No Abstract]   [Full Text] [Related]  

  • 4. GUCY2C ligand replacement to prevent colorectal cancer.
    Blomain ES; Pattison AM; Waldman SA
    Cancer Biol Ther; 2016 Jul; 17(7):713-8. PubMed ID: 27104761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanylyl cyclase C as a diagnostic and therapeutic target in colorectal cancer.
    Caspi A; Entezari AA; Crutcher M; Snook AE; Waldman SA
    Per Med; 2022 Sep; 19(5):457-472. PubMed ID: 35920071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer.
    Blomain ES; Merlino DJ; Pattison AM; Snook AE; Waldman SA
    Mol Pharmacol; 2016 Sep; 90(3):199-204. PubMed ID: 27251363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin and colorectal cancer.
    Otani K; Ishihara S; Yamaguchi H; Murono K; Yasuda K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Watanabe T
    Surg Today; 2017 Feb; 47(2):151-158. PubMed ID: 27061803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.
    Kang HW; Kim D; Kim HJ; Kim CH; Kim YS; Park MJ; Kim JS; Cho SH; Sung MW; Jung HC; Lee HS; Song IS
    Am J Gastroenterol; 2010 Jan; 105(1):178-87. PubMed ID: 19755965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
    Gallery M; Zhang J; Bradley DP; Brauer P; Cvet D; Estevam J; Danaee H; Greenfield E; Li P; Manfredi M; Loke HK; Rabino C; Stringer B; Williamson M; Wyant T; Yang J; Zhu Q; Abu-Yousif A; Veiby OP
    PLoS One; 2018; 13(1):e0191046. PubMed ID: 29370189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-15 derived from Guanylin-GC-C-expressing macrophages inhibits fatty acid synthase in adipocytes.
    Akieda-Asai S; Ida T; Miyazato M; Kangawa K; Date Y
    Peptides; 2018 Jan; 99():14-19. PubMed ID: 29097254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and colorectal cancer risk: the role of oxidative stress.
    Vermorken AJ; Zhu J; Andrès E
    Gut; 2014 Mar; 63(3):529-30. PubMed ID: 23903239
    [No Abstract]   [Full Text] [Related]  

  • 12. Association Among Obesity, Metabolic Health, and the Risk for Colorectal Cancer in the General Population in Korea Using the National Health Insurance Service-National Sample Cohort.
    Shin CM; Han K; Lee DH; Choi YJ; Kim N; Park YS; Yoon H
    Dis Colon Rectum; 2017 Nov; 60(11):1192-1200. PubMed ID: 28991084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
    Aka AA; Rappaport JA; Pattison AM; Sato T; Snook AE; Waldman SA
    Expert Rev Clin Pharmacol; 2017 May; 10(5):549-557. PubMed ID: 28162021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fat diet and colorectal cancer: myths and facts.
    Karunanithi S; Levi L
    Future Oncol; 2018 Mar; 14(6):493-495. PubMed ID: 29411651
    [No Abstract]   [Full Text] [Related]  

  • 15. Obesity and diabetes as prognostic factors in patients with colorectal cancer.
    Voutsadakis IA
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S109-S114. PubMed ID: 27989518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and colorectal cancer risk.
    Pendyala S; Holt P
    Gastroenterology; 2008 Mar; 134(3):896. PubMed ID: 18325409
    [No Abstract]   [Full Text] [Related]  

  • 17. Adiponectin and signal pathways in obesity-induced colon cancer.
    Huang XF; Chen J
    Gut; 2009 Aug; 58(8):1169; author reply 1169-70. PubMed ID: 19592697
    [No Abstract]   [Full Text] [Related]  

  • 18. Obesity and colorectal cancer.
    Hull M; Lagergren J
    Gut; 2014 Jan; 63(1):205. PubMed ID: 23645619
    [No Abstract]   [Full Text] [Related]  

  • 19. Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal Carcinogenesis.
    Kawashima K; Maeda K; Saigo C; Kito Y; Yoshida K; Takeuchi T
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in colorectal cancer: impact of body mass and exercise.
    Hall NR
    Gut; 2006 Jan; 55(1):8-10. PubMed ID: 16344571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.